Literature DB >> 24641893

Pain management for total hip arthroplasty.

Adam C Young1, Asokumar Buvanendran.   

Abstract

Total hip arthroplasty (THA) has been shown to improve long-term quality of life, although the immediate postoperative period can be associated with intense postoperative pain that hampers rehabilitation. Effective postoperative analgesia is paramount in the recovery period. The understanding and collaboration of the orthopaedic surgeon and the pain-management physicians will improve the perioperative outcome of THA. Appropriate pain management can reduce the associated total direct medical costs for lower extremity joint replacement surgeries by reducing hospital stays and the services needed during hospitalization. Factors contributing to the shorter lengths of stay include homogenous entities such as regular staff and continuity of nursing care, the use of timely and up-to-date information including expectations on a short stay, functional discharge criteria, early mobilization, and the use of a multimodal analgesia approach centered on opioid sparing.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24641893     DOI: 10.3113/jsoa.2014.0013

Source DB:  PubMed          Journal:  J Surg Orthop Adv        ISSN: 1548-825X


  9 in total

1.  Acupuncture provides short-term pain relief for patients in a total joint replacement program.

Authors:  Daniel J Crespin; Kristen H Griffin; Jill R Johnson; Cynthia Miller; Michael D Finch; Rachael L Rivard; Scott Anseth; Jeffery A Dusek
Journal:  Pain Med       Date:  2015-01-13       Impact factor: 3.750

2.  Comparison of fentanyl iontophoretic transdermal system and routine care with morphine intravenous patient-controlled analgesia in the management of early postoperative mobilisation: results from a randomised study.

Authors:  Richard M Langford; Kuang-Yi Chang; Li Ding; Jeffrey Abraham
Journal:  Br J Pain       Date:  2016-09-15

3.  Efficacy of intra-articular magnesium for postoperative analgesia in total hip arthroplasty.

Authors:  Xinxian Xu; Hong Wen; Yuezheng Hu; Zhongtang Liu; Xiaoyun Pan
Journal:  Biomed Rep       Date:  2017-01-09

4.  Clinical applicability of nursing outcomes in the evolution of orthopedic patients with Impaired Physical Mobility.

Authors:  Marcos Barragan da Silva; Miriam de Abreu Almeida; Bruna Paulsen Panato; Ana Paula de Oliveira Siqueira; Mariana Palma da Silva; Letícia Reisderfer
Journal:  Rev Lat Am Enfermagem       Date:  2015 Jan-Feb

5.  Expert Consensus on Clinical Use of an Orally Administered Dexketoprofen Plus Tramadol Fixed-Dose Combination in Moderate-To-Severe Acute Pain: A Delphi Study.

Authors:  Giustino Varrassi; Stefano Coaccioli; Josè De-Andrés; Magdi Hanna; Giorgos Macheras; Antonio Montero; Serge Perrot; Vincenzo Piras; Carmelo Scarpignato
Journal:  Adv Ther       Date:  2019-09-18       Impact factor: 3.845

6.  The effect of video-assisted discharge education after total hip replacement surgery: a randomized controlled study.

Authors:  Ozum Cetinkaya Eren; Nihal Buker; Hasan Atacan Tonak; Mustafa Urguden
Journal:  Sci Rep       Date:  2022-02-23       Impact factor: 4.379

7.  Ultrasound-guided "hourglass-pattern" fascia iliac block combined with sacral plexus and gluteal epithelial nerve block for an elderly hip fracture patient with organ failure.

Authors:  Huiyue Wang; Qianyu Li; Yong Ni
Journal:  Medicine (Baltimore)       Date:  2020-06-19       Impact factor: 1.817

8.  Fascia iliaca compartment block for analgesia in total hip replacement: A randomized controlled study protocol.

Authors:  Jiannan Song; Yan Qiao; Qi Zhou; Xizhe Zhang
Journal:  Medicine (Baltimore)       Date:  2020-09-11       Impact factor: 1.817

9.  Impact of the pericapsular nerve group (PENG) block on postoperative analgesia and functional recovery following total hip arthroplasty: a randomised, observer-masked, controlled trial.

Authors:  G Pascarella; F Costa; R Del Buono; R Pulitanò; A Strumia; C Piliego; E De Quattro; R Cataldo; F E Agrò; M Carassiti
Journal:  Anaesthesia       Date:  2021-07-01       Impact factor: 6.955

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.